This uncapped agreement includes 5 hybrid journal titles and 2 Gold OA journal titles during 2023, which allows authors from participating institutions to publish open access with no transactional article processing charges (APCs).
Portland Press, as the Biochemical Society’s publisher, works in partnership with researchers, institutions, and funders to share knowledge and advance the molecular biosciences.
Biochemical Society journals included in the CAUL Portland Read and Publish Agreement include:
Corresponding authors from institutions listed under 'Participating institutions' may publish immediately to open access on the publisher's platform once the article has been accepted, with no transactional APCs.
Submit your article via the publisher's platform.
You will be recognised as being eligible for open access publishing with no transactional APCs when you select your institution in the submission system.
Further information on the agreement and the Read & Publish process, including FAQs for authors, is available on the publisher's website.
The publisher submits open access articles and metadata to all relevant third-party repositories, such as PubMed Central, Europe PubMed Central, Google Scholar (all journals, crawled by Google), CAS, Web of Science, Scopus, and Embase.
Biochemical Society will notify authors of the Read & Publish agreement during the peer review process and supply an un-embargoed PDF of the version of record for institutional repositories.
Using Rightslink, library staff may set up an institutional account to
The publisher submits open access articles and metadata to all relevant third-party repositories, such as PubMed Central, Europe PubMed Central, Google Scholar (all journals, crawled by Google), CAS, Web of Science, Scopus, and Embase.